Description of Relugolix Use in Patients With Prostate Cancer Within the VHA
NCT06462014
·
clinicaltrials.gov ↗
COMPLETED
Status
507
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Relugolix
Sponsor
Pfizer